株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

D型肝炎:世界の治験レビュー

Hepatitis D Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 320837
出版日 ページ情報 英文 56 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
D型肝炎:世界の治験レビュー Hepatitis D Global Clinical Trials Review, H2, 2016
出版日: 2016年08月24日 ページ情報: 英文 56 Pages
概要

当レポートでは、D型肝炎の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • D型肝炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:D型肝炎の感染症の治験における割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:D型肝炎の感染症の治験における割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

D型肝炎治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Eiger BioPharmaceuticals, Inc.
    • REPLICor Inc.
    • MYR GmbH
    • Merck & Co., Inc.
    • Hepatera LLC
    • C. H. Boehringer Sohn AG & Co. KG
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • German Liver Foundation
    • National Taiwan University Hospital

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3664CTIDB

GlobalData's clinical trial report, "Hepatitis D Global Clinical Trials Review, H2, 2016" provides an overview of Hepatitis D clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis D. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hepatitis D Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Hepatitis D
      • Jul 20, 2016: Eiger BioPharmaceuticals Announces Completion of Dosing in Phase 2 LOWR HDV - 3 Study at National Institutes of Health
      • Jun 01, 2016: Maxwell Biotech Venture Fund's Portfolio Company Hepatera Announces Publication of Myrcludex B Clinical Results in Journal of Hepatology
      • May 25, 2016: Maxwell Biotech Venture Fund's Portfolio Company Hepatera Announces Start Of Second Phase 2 Clinical Trial Of Myrcludex B In Chronic Hepatitis B/D Infection
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hepatitis D Therapeutics, Global, Clinical Trials by Region, 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Hepatitis D Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2016*
  • Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Hepatitis D Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2016*
  • Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2016*
  • Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top